Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy
β Scribed by D. Francisci; F. Falcinelli; E. Schiaroli; M. Capponi; B. Belfiori; L. Flenghi; F. Baldelli
- Book ID
- 107705803
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 178 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. A point mutation from G to A at nucleotide (nt) 1896 of the precore region of hepatitis B virus (HBV) DNA has been shown to be associated with fulminant and severe hepatitis. Further studies have suggested that this point mutation, together with additional mutations in the precore p
## BACKGROUND. Reactivation of chronic hepatitis B virus (HBV) infection with the development of fulminant hepatitis induced by withdrawal of chemotherapy and/or corticosteroids (CS) is well known. However, less is known about liver dysfunction in patients with hepatitis C virus (HCV) who are unde
## Abstract The virological characteristics of hepatitis B virus (HBV) implicated in the reactivation of occult hepatitis B in patients who have received hematopoietic stemβcell transplantation or chemotherapy for the hematological malignancy are not well defined. Twentyβeight HBsAgβnegative patien